The companies intend to establish themselves in the fields of production, marketing and distribution of pharmaceutical products in Russia, inpharm.com reported.
The UPC which is a complex of interconnected production and infrastructure facilities is known to manufacture and sell medicines and medical equipment.
The cluster has received funds worth 27.3 bn roubles (around $860m) from Russia’s economic development programme between 2010 and 2015.